Development
Xylem Inc.
XYL
$125.13
-$0.24-0.19%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 40.64% | 50.43% | 26.25% | 13.84% | 13.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.64% | 50.43% | 26.25% | 13.84% | 13.83% |
| Cost of Revenue | 45.98% | 53.27% | 26.90% | 12.05% | 12.95% |
| Gross Profit | 31.94% | 45.80% | 25.19% | 16.92% | 15.29% |
| SG&A Expenses | 25.63% | 65.32% | 28.39% | 7.82% | 3.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.60% | 55.33% | 26.52% | 10.48% | 10.24% |
| Operating Income | 47.29% | 17.78% | 24.00% | 50.00% | 43.97% |
| Income Before Tax | 11.11% | 988.24% | -16.18% | 28.57% | 50.00% |
| Income Tax Expenses | -240.00% | 560.00% | -8.33% | 68.75% | 207.69% |
| Earnings from Continuing Operations | 78.52% | 1,166.67% | -17.86% | 20.73% | 31.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.52% | 1,166.67% | -17.86% | 20.73% | 31.86% |
| EBIT | 47.29% | 17.78% | 24.00% | 50.00% | 43.97% |
| EBITDA | 63.91% | 50.84% | 32.38% | 33.73% | 33.00% |
| EPS Basic | 34.17% | 847.45% | -28.00% | 20.62% | 32.08% |
| Normalized Basic EPS | 15.02% | -9.96% | 10.95% | 61.68% | 51.03% |
| EPS Diluted | 34.06% | 845.95% | -27.81% | 20.00% | 32.11% |
| Normalized Diluted EPS | 14.44% | -10.08% | 10.61% | 61.60% | 51.03% |
| Average Basic Shares Outstanding | 33.06% | 33.66% | 14.09% | 0.09% | -0.17% |
| Average Diluted Shares Outstanding | 33.74% | 33.85% | 14.44% | 0.16% | -0.17% |
| Dividend Per Share | 10.00% | 10.00% | 10.00% | 10.00% | 7.14% |
| Payout Ratio | -0.17% | -0.88% | 0.75% | -0.10% | -0.20% |